Page last updated: 2024-11-01

omeprazole and Leukemia, Promyelocytic, Acute

omeprazole has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patterson, WK1
Sage, RE1
Keefe, DM1

Other Studies

1 other study available for omeprazole and Leukemia, Promyelocytic, Acute

ArticleYear
Haemorrhagic gastritis in two patients treated with all-trans-retinoic acid in acute promyelocytic leukaemia.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:3

    Topics: Aged; Female; Gastritis; Gastrointestinal Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Male;

1994